Potential CF Therapy SNSP113 Able to Kill Drug-resistant Bacteria in Lab Study

Potential CF Therapy SNSP113 Able to Kill Drug-resistant Bacteria in Lab Study

Synspira’s SNSP113 Shows Ability to Completely Kill Drug-Resistant Bacteria in Lab, Study Reports

AUGUST 10, 2018

BY ANA PENA

 

IN CYSTIC FIBROSIS, NEWS.

The active ingredient of Synspira’s SNSP113, an inhaled investigational treatment for chronic lung infections, demonstrated an ability to completely eliminate antibiotic-resistant Pseudomonas aeruginosa bacteria, a major cause of lung disease in cystic fibrosis (CF) patients, according to a study done in the laboratory. These latest findings, together with its proven ability to kill other dangerous bacteria […] The post Synspira’s SNSP113 Shows Ability to Completely Kill Drug-Resistant Bacteria in Lab, Study Reports appeared first on Cystic Fibrosis News Today.

Read More